CD37 and acute myeloid leukemia: This prompted us to further evaluate CD37 cell-surface expression in a larger and more extensive AML patient cohort, and we examined the CD37 expression using the HH1 antibody in diagnostic peripheral blood samples from 59 AML patients and five healthy donors.